{"id":"W2590196392","doi":"10.1200/jco.2011.29.4_suppl.239","title":"Phase II trial of neoadjuvant full-dose gemcitabine, oxaliplatin, and radiation (RT) in patients with resectable (R) or borderline resectable (BR) pancreatic cancer.","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gemcitabine; Oxaliplatin; Regimen; Pancreatic cancer; Internal medicine; Adverse effect; Capecitabine; Chemotherapy; Surgery; Cancer; Gastroenterology; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00207223,0.001433302,0.001701578,0.0003677478,0.000440776,0.0008299003,0.000932931,0.001014832,0.004215388],"category_scores_gemma":[0.0008896764,0.0007014741,0.0008457675,0.0004397652,0.00100006,0.000792151,0.0004493078,0.002793131,0.0009367178],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009445997,"about_ca_system_score_gemma":0.002018042,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006819249,"about_ca_topic_score_gemma":0.002038668,"domain_scores_codex":[0.9996007,0.0002381433,0.00002084577,0.00005714039,0.00002437148,0.000058733],"domain_scores_gemma":[0.9992141,0.0001192283,0.0001379882,0.00007183093,0.00003004078,0.0004268994],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8154184,0.09381937,0.008698994,0.0006850606,0.0006663623,0.0003374703,0.0002766304,0.002048488,0.02406419,0.0002291508,0.004083598,0.04967228],"study_design_scores_gemma":[0.6700609,0.3171672,0.007237282,0.00003221666,0.0002298334,0.000265538,0.00005230017,0.001053149,0.00197213,0.0001409347,0.001772101,0.0000164605],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925125,0.001114664,0.0004422705,0.0005277068,0.000165032,0.002994212,0.0007421758,0.00007236301,0.001429169],"genre_scores_gemma":[0.9849065,0.001302668,0.002460064,0.000956733,0.0002530335,0.004921581,0.002202666,0.00002878793,0.002968052],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004215388,"threshold_uncertainty_score":0.01410186,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1364824038836659,"score_gpt":0.4728298448176145,"score_spread":0.3363474409339486,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}